Kamada
1 known investors
Kamada uses a proprietary platform to extract and purify protein therapeutics from human plasma, developing treatments for conditions such as alpha-1 antitrypsin deficiency (AATD) and cytomegalovirus (CMV) infection. It operates in the plasma-derived biopharmaceutical industry.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Kamada do?
- Kamada uses a proprietary platform to extract and purify protein therapeutics from human plasma, developing treatments for conditions such as alpha-1 antitrypsin deficiency (AATD) and cytomegalovirus (CMV) infection. It operates in the plasma-derived biopharmaceutical industry.
- Who are Kamada's investors?
- Kamada's investors include FIMI Opportunity Funds.